MetLife Investment Advisors »

Nuvectis Pharma shares owned by MetLife Investment Advisors

Quarter-by-quarter ownership of Nuvectis Pharma (NVCT) shares owned by MetLife Investment Advisors from 13F filings

Historical chart of MetLife Investment Advisors investment in Nuvectis Pharma

Tip: Access up to 7 years of quarterly data

All positions including Nuvectis Pharma held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nuvectis Pharma by MetLife Investment Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $178k 9.7k 18.39
2023-06-30 $63k 4.0k 15.97

More positions owned by MetLife Investment Advisors

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Alphabet Inc Class A Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
Alphabet Inc Class C Cap Stk Cl C (GOOG)
Micron Technology (MU)
Meta Platforms Inc Class A Cl A (META)
Tesla Motors (TSLA)
Eli Lilly & Co. (LLY)
Advanced Micro Devices (AMD)
Berkshire Hathaway Inc Class B Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)
Vanguard Short-term Bond Index Fun Short Trm Bond (BSV)

View all positions for MetLife Investment Advisors

Top funds holding Nuvectis Pharma

Tang Capital Management
BlackRock
Soleus Capital Management
Perceptive Advisors
Vanguard Capital Management
Iridian Asset Management
Geode Capital Management
Sphera Funds Management
Baldwin Brothers
Occam Crest Management
Susquehanna International
Alyeska Investment Group
Avidity Partners Management
Citadel Advisors
State Street Corporation

View all funds holding Nuvectis Pharma